What causes episodic ataxia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Episodic Ataxia

Episodic ataxia is primarily caused by genetic mutations affecting ion channels (EA1 and EA2 being most common), but can also result from metabolic disorders, migraines, benign positional vertigo, and various secondary causes including vascular, inflammatory, and toxic-metabolic etiologies. 1, 2

Primary Genetic Causes

Autosomal dominant channelopathies represent the most well-characterized primary causes:

  • EA1 is caused by heterozygous mutations in KCNA1, which encodes the α1 subunit of the neuronal voltage-gated potassium channel Kv1.1 3
  • EA2 (the most common type) is caused by heterozygous mutations in CACNA1A, encoding the α1A subunit of the P/Q-type voltage-gated calcium channel Cav2.1, primarily expressed in Purkinje cells 3, 4
  • EA6 results from heterozygous mutations in SLC1A3, encoding a glial excitatory amino acid transporter subunit (EAAT1) 3
  • Additional genetic causes include mutations in genes associated with other channelopathies: KCNA2, SCN2A, PRRT2, CLCN1, SCN1B, SCN9A, CACNA1E, and ATP1A3 2, 5, 6

The genetic landscape has expanded significantly, with EA now recognized as an unusual presentation of several other genetic disorders including SCA-14, SCA-27, SCA-42, AOA2, and CAPOS syndrome 2.

Metabolic Causes

Inborn errors of metabolism can present with intermittent ataxia during times of stress or illness 1:

  • Intermittent maple syrup urine disease 1, 2
  • Pyruvate dehydrogenase deficiency (PDHA1, PDHX mutations) 1, 2
  • Hartnup disease 1, 2
  • Type I citrullinemia 2
  • Thiamine and biotin metabolism defects 2
  • GLUT-1 deficiency 2
  • Mitochondrial disorders (ACO2 mutations) 2

MR spectroscopy may be useful when an underlying metabolic disorder is suspected 1.

Migraine-Related and Benign Causes

  • Basilar migraines are diagnosed based on clinical symptoms with normal neuroimaging 1
  • Benign paroxysmal vertigo is diagnosed by history, physical examination, and normal vestibular testing and neuroimaging 1
  • Childhood benign paroxysmal ataxia typically shows normal neuroimaging, which supports the diagnosis in the appropriate clinical setting 1

Secondary Causes

Secondary causes are more commonly encountered than primary EA 2:

  • Vascular causes including rotational occlusion of the vertebral artery (bow hunter syndrome), though rare 1
  • Inflammatory disorders 2
  • Toxic-metabolic causes 2

Diagnostic Approach

Head MRI without contrast is the preferred initial imaging for episodic ataxia, as it can identify metabolic disorders and genetic abnormalities, while normal imaging supports benign diagnoses like basilar migraine or benign paroxysmal ataxia 1. Imaging findings in EA2 may include vermian atrophy 1.

Common Pitfalls

  • Do not overlook EA due to phenotype-genotype variability and clinical overlap between primary and secondary causes 2
  • EA can be misdiagnosed as migraine, peripheral vestibular disorders, anxiety, or functional symptoms 2
  • For atypical phenotypes without clear EA1 or EA2 features, next-generation sequencing (whole exome sequencing) should be considered, as it identifies causative variants in approximately 50% of cases negative for CACNA1A mutations 6
  • Contrast-enhanced MRI is not supported for initial evaluation of episodic ataxia 1

The recognition that EA is highly treatable (with acetazolamide, 4-aminopyridine, dalfampridine, or fampridine for EA2) makes identifying the cause critically important 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.

Tremor and other hyperkinetic movements (New York, N.Y.), 2023

Research

Episodic ataxias.

Handbook of clinical neurology, 2018

Research

Episodic ataxia type 2.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2007

Research

Episodic ataxia associated with a de novo SCN2A mutation.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.